Charles River Laboratories International (CRL) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $253.8 million.
- Charles River Laboratories International's Long-Term Debt Repayments fell 2301.01% to $253.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 1950.7%. This contributed to the annual value of $1.5 billion for FY2024, which is 7539.17% up from last year.
- Charles River Laboratories International's Long-Term Debt Repayments amounted to $253.8 million in Q3 2025, which was down 2301.01% from $738.3 million recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Long-Term Debt Repayments peaked at $2.5 billion during Q2 2021, and registered a low of $149.4 million during Q1 2025.
- Over the past 5 years, Charles River Laboratories International's median Long-Term Debt Repayments value was $408.2 million (recorded in 2022), while the average stood at $666.4 million.
- Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 200410.49% in 2021, then plummeted by 8340.89% in 2023.
- Quarter analysis of 5 years shows Charles River Laboratories International's Long-Term Debt Repayments stood at $1.1 billion in 2021, then plummeted by 61.21% to $408.2 million in 2022, then fell by 21.43% to $320.8 million in 2023, then crashed by 44.89% to $176.8 million in 2024, then surged by 43.57% to $253.8 million in 2025.
- Its Long-Term Debt Repayments was $253.8 million in Q3 2025, compared to $738.3 million in Q2 2025 and $149.4 million in Q1 2025.